The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
May 14th 2024
The FDA has extended the review period for palopegteriparatide in treatment of hyperparathyroidism in adult patients by 3 months to August 14, 2024.
AFib Risk Higher for T1D Patients with Renal Complications, Poor Glycemic Control
September 15th 2017After adjusting for comorbidities, education level, birthplace, and duration of diabetes, the data showed that men with T1D faced a slightly higher risk of AFib, but women with T1D faced a 50% higher risk of developing AFib.
Experts Debate Beta-Blocker Use With Simultaneous AFib and Heart Failure
August 3rd 2017Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.